Carolina Infusion, LLC

Has Carolina Infusion, LLC received an FDA warning letter about GLP-1 drugs?

No FDA warning letter to Carolina Infusion, LLC naming a GLP-1 drug appears in FDA’s posted letters as of Nov 15, 2026. The company is listed here because openFDA has 11 drug recall reports for it naming semaglutide and tirzepatide, the latest initiated Sep 10, 2026.

FDA records in this index name Carolina Infusion, LLC from Aug 26, 2022 to Sep 10, 2026.

Names in FDA records
Carolina Infusion, LLC; Carolina Infusion
Type named in FDA records
Not stated
FDA warning letters
0
Drug recall reports
11
Drugs named
Semaglutide, Tirzepatide
Latest record
Sep 10, 2026

FDA warning letters

FDA records print this firm both as “Carolina Infusion, LLC” and “Carolina Infusion”. They are shown together because one form has no legal ending and no other firm with that name appears in this index’s data; each row below gives the name as FDA printed it.

No FDA warning letters in this index.

Drug recalls

Record
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0026-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0019-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0018-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0027-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0030-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0028-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0029-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infus...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0017-2027
Aug 26, 2022Carolina InfusionSemaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.Lack of Assurance of SterilityClass IICompletedD-1521-2022
Aug 26, 2022Carolina InfusionSemaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.Lack of Assurance of SterilityClass IICompletedD-1519-2022
Aug 26, 2022Carolina InfusionSemaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.Lack of Assurance of SterilityClass IICompletedD-1520-2022

FDA compounding inspections and actions

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists one facility under this exact legal name. These entries cover all of the facility’s compounding, not only GLP-1 drugs.

Carolina Infusion, Ridgeland, SC (503A)

4 listed actions, including 3 Form 483s and 1 warning letter (2022 to 2026).

Document
Aug 18, 2026Form 483483 Issued 08/18/2026fda.gov
Jan 24, 2025Form 483483 Issued 01/24/2025FDA copy (archived)
May 22, 2023Warning letterWarning Letter (05/22/2023)FDA copy (archived)
Aug 12, 2022Form 483483 Issued 08/12/2022FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own.

Pharmacy pages with the same legal name, built from FDA’s 503B list and compounding inspections and actions page: Carolina Infusion, Ridgeland, SC.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.